Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 15 - Jul 20
For Your Every Summer RSVP, with Code: SUMMER15
Description
Patient CapitalDiscover the compelling insights of 'Patient Capital', a transformative guide that delves into overcoming barriers to long term investments essential for tackling the world's pressing issues, such as climate change and decaying infrastructure. As we face a critical juncture, with the public sector struggling to bridge the investment gap, long term investorssuch as pension funds, sovereign wealth funds, and university endowmentsemerge as key players in
Discover the compelling insights of 'Patient Capital', a transformative guide that delves into overcoming barriers to long-term investments essential for tackling the world's pressing issues, such as climate change and decaying infrastructure. As we face a critical juncture, with the public sector struggling to bridge the investment gap, long-term investors—such as pension funds, sovereign wealth funds, and university endowments—emerge as key players in addressing these challenges. Written by renowned Harvard Business School Professors Victoria Ivashina and Josh Lerner, this brand new trade binding edition, published by Princeton University Press in 2019, provides a thoroughly researched yet accessible perspective on the dynamics of patient capital investing.The book reveals the significant hurdles that institutional investors encounter in their pursuit of meaningful, long-term returns. By weaving memorable stories and tangible examples throughout the narrative, 'Patient Capital' not only articulates the necessity for a paradigm shift toward more strategic long-run investments but also equips investors with practical solutions to overcome existing limitations. Grounded in compelling evidence, this work illustrates how aligning incentives within fund management can foster successful outcomes.
By understanding how to navigate the complex landscape of patient capital, investors can potentially unlock unparalleled rewards that benefit both their portfolios and the broader society. Embrace the opportunity to transform investment strategies for a sustainable future with this essential read that champions both profitability and purpose. Order now to secure your copy!
Note: Shipping for this item is free. Please allow up to 6 weeks for delivery. Once your order is placed, it cannot be cancelled. ISBN: 9780691186733.
Note: Shipping for this item is free. Please allow up to 6 weeks for delivery. Once your order is placed, it cannot be cancelled.
Condition: BRAND NEW
ISBN: 9780691186733
Format: Trade binding
Year: 2019
Publisher: Princeton University Press
Description:
How to overcome barriers to the long-term investments that are essential for solving the world's biggest problems
There has never been a greater need for long-term investments to tackle the world's most difficult problems, such as climate change and decaying infrastructure. And it is increasingly unlikely that the public sector will be willing or able to fill this gap. If these critical needs are to be met, the major pools of long-term, patient capital-including pensions, sovereign wealth funds, university endowments, and wealthy individuals and families-will have to play a large role. In this accessible and authoritative account of long-term capital investment, two leading experts on the subject, Harvard Business School professors Victoria Ivashina and Josh Lerner, highlight the significant hurdles facing long-term investors and propose concrete ways to overcome these difficulties.
Presenting the best evidence in an engaging way by using memorable stories and examples, Patient Capital describes how large investors increasingly want and need long-run investments that have the potential to deliver greater returns than those in the public markets. Yet success in such investments has been the exception. Performance has suffered from both the limitations of investors and the internal structure of their fund managers, often resulting in the wrong incentives and a lack of long-term planning.
Yet the challenges facing long-term investors can be surmounted and the rewards are potentially large, both for investors and society as a whole. Patient Capital shows how to make long-term investment work better for everyone.
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.9 ★★★★★
Based on 642 reviews
Sort
Product Reviews
★★★★★ 5
Great Quality and Fit!
Very nice sweater! It’s well made from quality materials. It is soft and stretchy.
Highly recommend this casual sweater! I have four and will probably pick up a couple more. Can’t go wrong!!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 26, 2026
★★★★★ 4
Looks amazing
Very nice material and feel. I got complimented on this in public and it made my day, and completely validated the purchase for me. A soft material that looks and feels right when worn. I will buy more.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 6, 2026
★★★★★ 5
Great sweater, high quality
High quality & true to size! My fiance wore this for our engagement party and got so many compliments.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 20, 2026
★★★★★ 5
Beautiful sweater
Color: Dark Brown, Size: Small
This sweater is gorgeous! It looks so great on my husband. Color, fit and material was so nice!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 13, 2026
★★★★★ 5
Very good quality..looks expensive
Stunning and true to size
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 29, 2025